List of Sympazan drug patents
Sympazan is owned by Aquestive.
Sympazan contains Clobazam.
Sympazan has a total of 2 drug patents out of which 0 drug patents have expired.
Sympazan was authorised for market use on 01 November, 2018.
Sympazan is available in film;oral dosage forms.
The generics of Sympazan are possible to be released after 03 April, 2024.
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8765167 | AQUESTIVE | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
Feb, 2024
(1 year, 19 days from now) | |
| US8603514 | AQUESTIVE | Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
Apr, 2024
(1 year, 2 months from now) | |
Drugs and Companies using CLOBAZAM ingredient
Market Authorisation Date: 01 November, 2018
Treatment: NA
Dosage: FILM;ORAL
Sympazan is owned by Otter Pharms.
Sympazan contains Clobazam.
Sympazan has a total of 1 drug patent out of which 0 drug patents have expired.
Sympazan was authorised for market use on 01 November, 2018.
Sympazan is available in film;oral dosage forms.
Sympazan can be used as method of treating seizures.
The generics of Sympazan are possible to be released after 05 September, 2039.
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US11541002 | OTTER PHARMS | NA |
Sep, 2039
(16 years from now) | |
Drugs and Companies using CLOBAZAM ingredient
Market Authorisation Date: 01 November, 2018
Treatment: Method of treating seizures
Dosage: FILM;ORAL
availability in other generic markets.
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic